PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Nov-2020 COVID-19: Implications of Early Vaccine Data Pfizer and BioNTech
12-Nov-2020 PFIZER ANNOUNCES POSITIVE RESULTS FROM FIFTH PHASE 3 TRIAL OF ABROCITINIB, EVALUATING SAFETY AND EFFICACY ACROSS DIFFERENT DOSING REGIMENS Pfizer
12-Nov-2020 Poster presentation with ACD856 in Alzheimer's now available on AlzeCure's website AlzeCure Pharma AB
12-Nov-2020 Sunstone announces new investment in neuropsychiatric company Synendos Therapeutics Sunstone Life Science Ventures
12-Nov-2020 Original-Research: MagForce AG (von GBC AG) MagForce AG
12-Nov-2020 Byondis to Present at the Jefferies 2020 Virtual Healthcare Conference B3C newswire
12-Nov-2020 Epigenomics AG reports financial results for the first nine months of 2020 Epigenomics AG
12-Nov-2020 Vita 34 manages crisis environment well with a strong third quarter Vita 34 AG
12-Nov-2020 EVOTEC EXPANDS OXFORDSHIRE SITE INTO A FULLY-INTEGRATED R&D CENTRE NAMED 'DOROTHY CROWFOOT HODGKIN CAMPUS' Evotec SE
12-Nov-2020 EVOTEC SE REPORTS RESULTS FOR THE FIRST NINE MONTHS 2020 AND PROVIDES CORPORATE UPDATE Evotec SE
12-Nov-2020 Medios AG: Further dynamic growth Medios AG
12-Nov-2020 Biotest AG: Biotest increases adjusted 9-month EBIT by over 21% to € 52 million Biotest AG
12-Nov-2020 Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting Kodiak Sciences Inc.
11-Nov-2020 MorphoSys Reports Nine Months and Third Quarter 2020 Results MorphoSys AG
11-Nov-2020 Heron Therapeutics to Present at Several Upcoming Virtual Investor Conferences Heron Therapeutics, Inc.
11-Nov-2020 PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution PDL BioPharma, Inc.
11-Nov-2020 MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology MorphoSys AG
11-Nov-2020 Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab MorphoSys AG
11-Nov-2020 Tezepelumab NAVIGATOR Phase III trial met primary endpoint of a statistically significant and clinically meaningful reduction in exacerbations in a broad population of patients with severe asthma AtraZeneca
11-Nov-2020 Nass Valley Gateway Ltd.: Nass Valley Gateway Announces a New Marketing Partnership With Digital Agency, Branded Book Nass Valley Gateway Ltd.